Yildirim V, Doganci S, Cinar S, Eskin M B, Ozkan G, Eksert S, Ince M E, Dogrul A
Department of Anesthesiology and Intensive Care, Gulhane Military Academy of Medicine, Ankara, Turkey.
Eur Rev Med Pharmacol Sci. 2014 Nov;18(22):3425-34.
Opioid-induced hyperalgesia is well known complication of acute high dose and chronic opioid therapy. In this study, we evaluated development of opioid-induced hyperalgesia following intraoperative short-term use of µ-opioid agonist fentanyl after coronary artery bypass surgery.
100 patients undergoing elective coronary artery bypass graft surgery is divided into two groups. In group I (low dose), anesthesia was induced with propofol 1-2.5 mg/kg and fentanyl 2 mcg/kg, in group II (high dose) fentanyl 40-70 mcg/kg was used. In group I, propofol 5-10 mg/kg/h, fentanyl 1-3 mcg/kg/h, in group II fentanyl 5-10 mcg/kg/h was used for maintenance of anesthesia. The tactile and thermal thresholds were measured before surgery and in 1st, 3rd and 7th postoperative days by using Von Frey filaments and a thermal source, respectively.
Tactile thresholds were significantly decreased at the first (6,08±0.21 and 3.76±0.13 g; p<0.001) and third (6.76±0.24 and 4.96±0.16 g; p<0.001) postoperative days compared to baseline preoperative values (7.72±0.26, and 7.60±0.21 g; p=816) in two groups. Postoperative 1st (13.45±0.33 and 10.05±0.24 sec; p<0.001) and 3rd day (14.77±0.28 and 13.17±0.26 sec; p<0.001) assessments showed a statistically significant thermal hyperalgesia compared to the preoperative baseline values (16.67±0.51 and 16.45±0.42 sec; p=0.997) in two groups. This decrease in both tactile and thermal thresholds returned to baseline control values at the 7th day of measurement.
Our results showed that patients undergoing coronary artery bypass surgery receiving fentanyl anesthesia developed postoperative tactile allodynia and thermal hyperalgesia and this was more prominent in high dose group.
阿片类药物诱导的痛觉过敏是急性大剂量和慢性阿片类药物治疗中众所周知的并发症。在本研究中,我们评估了冠状动脉搭桥手术后术中短期使用μ阿片受体激动剂芬太尼后阿片类药物诱导的痛觉过敏的发生情况。
100例行择期冠状动脉搭桥手术的患者分为两组。第一组(低剂量组),用1 - 2.5mg/kg丙泊酚和2μg/kg芬太尼诱导麻醉,第二组(高剂量组)使用40 - 70μg/kg芬太尼。第一组,用5 - 10mg/kg/h丙泊酚和1 - 3μg/kg/h芬太尼维持麻醉,第二组用5 - 10μg/kg/h芬太尼维持麻醉。分别在手术前以及术后第1、3和7天,使用von Frey细丝和热源测量触觉和热阈值。
与术前基线值(7.72±0.26和7.60±0.
21g;p = 0.816)相比,两组在术后第1天(6.08±0.21和3.76±0.13g;p<0.001)和第3天(6.76±0.24和4.96±0.16g;p<0.001)触觉阈值显著降低。与术前基线值(第一组16.67±0.51秒,第二组16.45±0.42秒;p = 0.997)相比,术后第1天(13.45±0.33和10.05±0.24秒;p<0.001)和第3天(14.77±0.28和13.17±0.26秒;p<0.001)的评估显示两组均有统计学意义的热痛觉过敏。在测量的第7天,触觉和热阈值的这种降低恢复到基线对照值。
我们的结果表明,接受芬太尼麻醉的冠状动脉搭桥手术患者术后出现触觉异常性疼痛和热痛觉过敏,且在高剂量组中更为明显。